News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • No major news articles were published this hour, leaving markets without fresh headline drivers.
  • Global equity indices traded muted on light volume amid the absence of new economic data or corporate news.
  • Treasury yields drifted modestly with no sudden moves as traders awaited scheduled releases.
  • Oil and commodity prices were rangebound without supply-shock headlines.
  • No government or central bank announcements occurred this hour to shift policy expectations.
  • Volatility measures fell to multi-hour lows as headline flow remained sparse.

Latest Articles

Nasdaq Reports July 2026 Volumes

Nasdaq Reports July 2026 Volumes

Nasdaq has published its trading volume statistics for July 2026 on its Investor Relations website, providing transparency on market activity. The data highlights ongoing market operations through Nasdaq's technology platform which continues to support global financial markets.

Sight Sciences Reports Second Quarter 2026 Financial Results

Sight Sciences Reports Second Quarter 2026 Financial Results

Sight Sciences delivered significant growth in Q2 2026 with revenues increasing 20% year-over-year. Interventional Dry Eye revenues surged 704% driven by higher volumes and selling prices. The company achieved strong gross margins, improved cash usage, and decreased operating expenses, leading to a 63% reduction in net loss compared to the prior ye…

EverCommerce Announces Second Quarter 2026 Financial Results

EverCommerce Announces Second Quarter 2026 Financial Results

EverCommerce Inc. announced its Q2 2026 financial results with revenue up 2.7% year-over-year to $152 million and net income from continuing operations increasing to $9.7 million. Adjusted EBITDA was slightly lower than the previous year at $44.5 million but exceeded the upper end of guidance. The company repurchased 1.4 million shares and updated …

Cytek Biosciences Reports Second Quarter 2026 Financial Results

Cytek Biosciences Reports Second Quarter 2026 Financial Results

Cytek Biosciences reported a 6% year-over-year revenue increase to $48.1 million for Q2 2026, driven by strong instrument sales growth in the US and China and expanding recurring revenue from services and reagents. The company launched new products including Cytek Borealis and Aurora Evo with enhanced features. Despite the revenue growth and improv…

ThredUp Announces Second Quarter 2026 Results

ThredUp Announces Second Quarter 2026 Results

ThredUp Inc. announced its Q2 2026 results, achieving record quarterly revenue of $90.8 million, up 17% year-over-year, and active buyers increasing 21%. Gross margin improved slightly to 79.9%, and adjusted EBITDA reached $4.8 million. Despite strong quarterly performance, the company lowered its H2 2026 guidance due to economic uncertainty impact…

Hudson Technologies Reports Second Quarter 2026 Results

Hudson Technologies Reports Second Quarter 2026 Results

Hudson Technologies reported second quarter 2026 revenues of $78.3 million, an 8% increase year-over-year driven by a 12% sales volume growth offset by 6% lower selling prices due to refrigerant market conditions. The company restored operations quickly after a tornado-impacted facility disruption, announced a partnership with Icorium to scale adva…

LifeVantage Welcomes Terrence Moorehead as Chief Executive Officer

LifeVantage Welcomes Terrence Moorehead as Chief Executive Officer

LifeVantage Corporation named Terrence Moorehead as its new President and CEO. Moorehead brings over 25 years of leadership experience in consumer wellness and digital transformation, previously leading Nature's Sunshine Products through successful brand modernization and growth. The company aims to leverage his expertise to accelerate growth and s…

Encore Capital Group Announces Second Quarter 2026 Financial Results

Encore Capital Group Announces Second Quarter 2026 Financial Results

Encore Capital Group announced its second quarter 2026 financial results, highlighting record U.S. portfolio purchases of $372 million and global collections reaching a record $737 million, a 13% year-over-year increase. Despite absorbing $1.00 per share in refinancing costs related to a $1 billion debt refinancing, the company delivered earnings p…

Phillips Edison & Company Declares Monthly Dividend

Phillips Edison & Company Declares Monthly Dividend

Phillips Edison & Company, a leading owner and operator of grocery-anchored neighborhood shopping centers, declared a monthly dividend of $0.1083 per share payable on September 1, 2026. This dividend reflects the company's strong operational performance and steady cash flow from its retail real estate portfolio.

Satellogic Reports Second Quarter 2026 Financial Results

Satellogic Reports Second Quarter 2026 Financial Results

Satellogic Inc. reported a substantial 259% year-over-year revenue increase to $15.9 million for Q2 2026, marking the company's first quarter of positive operating income ($0.3 million) and positive adjusted EBITDA ($2.8 million). The company strengthened its capital position with $112.8 million cash on hand and executed key contracts in sovereign …

Trupanion Reports Second Quarter 2026 Results

Trupanion Reports Second Quarter 2026 Results

Trupanion, Inc., a leading provider of medical insurance for cats and dogs, reported strong financial results for the second quarter of 2026, including 11% total revenue growth and a 14% increase in subscription revenue. The company improved adjusted EBITDA and free cash flow compared to the previous year. Trupanion also announced an extraordinary …

Datadog to Present at Upcoming Investor Conferences

Datadog to Present at Upcoming Investor Conferences

Datadog, a leading AI-driven observability and security platform, announced that its management will present at three major investor conferences in August and September 2026. These presentations offer opportunities for the company to communicate its growth prospects and technology advancements to investors and analysts, with live webcasts and repla…

PacBio Announces Second Quarter 2026 Financial Results

PacBio Announces Second Quarter 2026 Financial Results

Pacific Biosciences of California, Inc. (PacBio) announced its financial results for Q2 2026, reporting total revenue of $39.0 million, largely steady compared to the prior year quarter. The company began a global commercial rollout of its SPRQ-Nx chemistry, achieving a $345 list price per genome sequencing and highlighting several scientific publi…

OraSure Announces Second Quarter 2026 Financial Results

OraSure Announces Second Quarter 2026 Financial Results

OraSure Technologies announced second quarter 2026 financial results with $30.6 million in revenue, representing sequential growth and slight year-over-year decline. The company achieved FDA clearances for innovative diagnostic products, including the Colli-PeeDx urine collection device and an updated Ebola rapid test, aligning with their strategy …

Inspired Reports Second Quarter 2026 Results

Inspired Reports Second Quarter 2026 Results

Inspired Entertainment, Inc. reported a 6% sequential increase in Q2 2026 revenue to $60.8 million, despite a higher UK remote gaming duty. Adjusted EBITDA rose 14% sequentially to $27.1 million, achieving a company-record 45% margin. The company strengthened cash flow and reduced debt while maintaining a strong product pipeline and geographic expa…

Standard BioTools Reports Second Quarter 2026 Financial Results

Standard BioTools Reports Second Quarter 2026 Financial Results

Standard BioTools Inc. reported Q2 2026 revenue of $20.1 million, a 7.6% decrease year-over-year, with improved adjusted EBITDA loss by 84%. The company is progressing toward a merger with Treeline Biosciences anticipated to close by the end of 2026, aiming to enhance shareholder value through exposure to a promising therapeutic pipeline. Operating…